Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 530-533, December 2009

A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique

  • Sheng Zi Wang

      Affiliations

    • Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, China
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai 200031, China.
  • ,
  • Ji Li

      Affiliations

    • Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, China
  • ,
  • Curtis T. Miyamoto

      Affiliations

    • Department of Radiation Oncology, Temple University Hospital, USA
  • ,
  • Fu Chen

      Affiliations

    • Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, China
  • ,
  • Li Fen Zhou

      Affiliations

    • Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, China
  • ,
  • Hai Yan Zhang

      Affiliations

    • Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, China
  • ,
  • Gang Yang

      Affiliations

    • Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, China
  • ,
  • Wei Fang Wang

      Affiliations

    • Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, China
  • ,
  • Ming Guo

      Affiliations

    • Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, China
  • ,
  • Xiao Chen Ni

      Affiliations

    • Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, China
  • ,
  • Lei Wang

      Affiliations

    • Department of Radiation Oncology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, China

Received 26 October 2008; received in revised form 16 September 2009; accepted 29 September 2009. published online 23 October 2009.

Abstract 

Purpose

This study evaluates the difference in damage to middle ear function with CRT and IMRT techniques in the treatment of nasopharyngeal carcinoma (NPC). We explore the isthmus of the Eustachian tube (ET) as the key anatomic site for the prevention of radiation-induced otitis media with effusion.

Methods and materials

Eighty-two patients with NPC were divided into two groups: 40 patients treated with CRT and 42 patients treated with IMRT. The difference between dosage over the middle ear cavity and the isthmus of the ET was evaluated in both CRT group and IMRT group. All patients underwent hearing tests including pure tone audiometry and impedance audiometry before and after RT.

Results

The dosage difference to the middle ear cavity and isthmus between these two groups was statistically significant (p<0.05). The difference in hearing test results between these two groups was also statistically significant (p<0.05). If we limited the dose to the middle ear cavity under 34Gy and the dose to the isthmus under 53Gy with IMRT, we may decrease radiation-induced OME even with the larger 2.25Gy fraction size.

Conclusions

IMRT may have better protected the middle ear function compared with the CRT technique, even with larger fraction sizes than for the conventional CRT technique.

Keywords: Nasopharyngeal carcinoma, Radiotherapy, Radiation-induced otitis media with effusion

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(09)00561-1

doi:10.1016/j.radonc.2009.09.013

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 530-533, December 2009